The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Jul. 03, 2020
Applicant:

Biodev, Llc, Edison, NJ (US);

Inventors:

Robert Shorr, Edison, NJ (US);

Jeffrey Schwartz, Edison, NJ (US);

Assignee:

BioDev, LLC, Edison, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/708 (2006.01); A61P 35/04 (2006.01); A61K 31/25 (2006.01); A61K 31/716 (2006.01);
U.S. Cl.
CPC ...
A61K 31/708 (2013.01); A61K 31/25 (2013.01); A61K 31/716 (2013.01); A61P 35/04 (2018.01);
Abstract

Compositions for the treatment, prevention of, proliferation of, or killing of cells associated with metastatic progression of cancer in a cancer patient are disclosed. More specifically, compositions containing a single type of glyceride, fatty acid, or fatty acid derivative, mixtures thereof, or glycerides and/or fatty acids/fatty acid derivatives in combination with cancer metabolism disruptors, chemotherapeutics and modulators of immune response, are disclosed. Compositions disclosed herein include formulations of monolaurin, and formulations including monolaurin and additional components. Also, methods of treating metastatic cancer and/or preventing cancer relapse in a cancer patient by administering compositions containing a single type of glyceride, fatty acid, or fatty acid derivative, mixtures thereof, or glycerides and/or fatty acids/fatty acid derivatives in combination with cancer metabolism disruptors, chemotherapeutics and modulators of immune response, are disclosed. The compositions and methods disclosed herein are useful for killing circulating cancer cells that cause metastasis and cancer relapse.


Find Patent Forward Citations

Loading…